logo-loader
RNS
Physiomics PLC

Director Dealing

/**/ h1{margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;text-align:center;font-size:16.0pt;font-family:"Trebuchet MS","sans-serif";}h3{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:12.0pt;font-family:"Trebuchet MS","sans-serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: purple } .ah{size:595.3pt 841.9pt;margin:72.0pt 46.3pt 72.0pt 89.85pt;}div.ah{}p.cl{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";text-align: right}p.cm{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-weight: bold; margin-bottom: 12.1pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.1pt}span.ci{color:black}p.cn{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-weight: bold; margin-bottom: 0cm; margin-left: 0cm; margin-right: 0cm; margin-top: 12.1pt; text-align: center}p.co{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-weight: bold; margin-bottom: 0cm; text-align: center; text-autospace: none}p.cp{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-div: italic; margin-bottom: 0cm; text-align: center; text-autospace: none}p.cq{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-autospace: none}p.cr{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify} p.cs{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:110%}p.ct{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-weight: bold; line-height: 110%; margin-bottom: 0cm; text-align: justify}p.cu{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-weight: bold; line-height: 110%; margin-bottom: 0cm; text-align: justify; text-autospace: none}span.bz{font-size:10.0pt; line-height:110%}p.cv{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:110%;text-autospace:none}p.cw{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-weight: bold; margin-bottom: 0cm; text-align: justify}span.bw{font-size:10.0pt;color:black}p.cx{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-weight: bold; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -9.4pt; margin-top: .05pt; text-align: center}table.cy{width:500.0pt;margin-left:-1.0cm;border-collapse:collapse;border:none}td.bs{width:7.04%;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt} p.cz{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:13.55pt;margin-bottom: 3.0pt;margin-left:0cm}td.bq{width:92.96%;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}p.da{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:11.9pt;margin-bottom: 3.0pt;margin-left:0cm}td.bp{width:7.04%;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}td.bn{width:33.5%;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.db{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:14.9pt;margin-bottom: 3.0pt;margin-left:0cm}td.bl{width:59.46%;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.dc{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:8.8pt;margin-bottom: 3.0pt;margin-left:0cm}tr.bh{height:4.0pt}td.bk{width:7.04%;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:4.0pt} td.bi{width:92.96%;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:4.0pt}p.dd{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:56.3pt;margin-bottom: 3.0pt;margin-left:0cm}p.de{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:11.55pt;margin-bottom: 3.0pt;margin-left:0cm}p.df{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:15.9pt;margin-bottom: 3.0pt;margin-left:0cm}p.dg{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:6.65pt;margin-bottom: 3.0pt;margin-left:0cm}td.bd{width:92.96%;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.dh{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:8.85pt;margin-bottom: 3.0pt;margin-left:0cm}p.di{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:14.6pt;margin-bottom: 3.0pt;margin-left:0cm}p.dj{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:9.7pt;margin-bottom: 3.0pt;margin-left:0cm}tr.av{height:42.5pt} td.az{width:7.04%;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:42.5pt}td.ay{width:33.5%;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:42.5pt}td.aw{width:59.46%;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:42.5pt}p.dk{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:0cm;margin-bottom: 3.0pt;margin-left:0cm}p.dl{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:7.95pt;margin-bottom: 3.0pt;margin-left:0cm}table.dm{width:293.6pt;border-collapse:collapse;border:none}td.as{border:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt}p.dn{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";font-weight: bold; margin-bottom: 3.0pt; margin-left: 0cm; margin-right: 56.3pt; margin-top: 3.0pt}td.ar{width:49.3%;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}td.ap{border:solid windowtext 1.0pt;border-top:none; padding:0cm 5.4pt 0cm 5.4pt} p.do{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:6.0pt;margin-right:56.3pt;margin-bottom: 8.0pt;margin-left:0cm;line-height:107%}td.ao{width:49.3%;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.dp{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:6.65pt; margin-bottom:3.0pt;margin-left:29.9pt;text-indent:-21.25pt;line-height:107%}span.am{font-family:"Tahoma","sans-serif";color:black}p.dq{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-right:8.8pt}p.dr{margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:0cm;font-size:11.0pt;font-family:"Trebuchet MS","sans-serif";margin-top:3.0pt;margin-right:13.7pt;margin-bottom: 3.0pt;margin-left:0cm} /**/
RNS Number : 8063H
Physiomics PLC
05 August 2019
 

 

2 August 2019

Physiomics plc

("Physiomics") or (the "Company")

 

Director Dealing

 

 

The Company announces that it received notice today that Christophe Chassagnole, the Company's Chief Operating Officer, acquired 100,000 ordinary shares of 0.4 pence each in the capital of the Company ("Ordinary Shares") at 3.38 pence per share.

 

Following the acquisition, Dr Chassagnole is interested in 517,008 Ordinary Shares representing approximately 0.72% of the Company's issued share capital.

 

 

Enquiries:

 

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

 

Strand Hanson Ltd (NOMAD)

Richard Tulloch & James Dance

+44 (0) 20 7409 3494

 

Hybridan LLP (Broker)

Claire Louise Noyce

+44 (0) 20 3764 2341

 

Notes to Editor

 

About Physiomics

 

Physiomics plc (AIM: PYC) is a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry. The Company's Virtual Tumour™ technology uses computer modelling to predict the effects of cancer drugs and treatments to improve the success rate of drug discovery and development projects while reducing time and cost. The predictive capability of Physiomics' technologies have been confirmed by over 70 projects, involving over 30 targets and 60 drugs, and has worked with clients such as Merck KGaA, Merck & Co, Bayer and Lilly.

 

Based in Oxford UK, the Company works with clients worldwide to support their pre-clinical and clinical oncology development programs. Its team of scientists and computer modelling experts provide bespoke solutions encompassing data, analytics and insight.

 

Physiomics senior management has academic and commercial expertise, including over 120 years collectively of working in oncology and/or computational biology and over 120 publications in peer reviewed journals that have attracted thousands of citations.

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christophe Chassagnole

2

Reason for the notification

a)

Position/status

Director, COO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Physiomics plc

b)

LEI

213800A71DSZ6ABMTQ91

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary share

 

 

GB00BDR6W943

b)

Nature of the transaction

Acquisition of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

3.38p

100,000

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

100,000

At 3.38p

e)

Date of the transaction

02-08-2019

f)

Place of the transaction

XLON, AIM

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHPTMATMBJMBRL

Quick facts: Physiomics PLC

Price: 2.5

Market: AIM
Market Cap: £1.8 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE